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Abstract: Many papers have been written on the anticancer properties of dietary flavonoids, and a 
range of potential mechanisms of action of flavonoids. However, most dietary flavonoids - notably 
polyphenolic flavonoids—have very poor ADME properties, and the levels necessary to stop 
growth of tumour cells cannot be sustained in a human body trough dietary intake alone. At present 
no flavonoid based drugs are clinically used in cancer therapy. Thus, whereas epidemiological and 
pre-clinical data seem to indicate a high potential for flavonoids, from the point of view of the 
pharmaceutical industry and drug developers, they are considered poor candidates. The flavones—
which constitute a subgroup of the flavonoids—show some structural analogy with oestrogen and 
are known to interact with human oestrogen receptors, either as agonist or as antagonist. They are 
classed as phytoestrogens, and may play a role in cancer prevention through a mechanism of action 
possibly similar to that of the clinically used medication tamoxifen. Flavones are abundantly present 
in common fruits and vegetables, many of which have been associated with cancer prevention. Their 
phytoestrogen activity makes that they can assert their biological action at concentrations that are 
realistically achievable in the human systemic circulation.  
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Figure 1. Structural similarity between estradiol and the flavone apigenin. 
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